Kewaunee Scientific Corp

Kewaunee Scientific Corp (KEQU) Stock Analysis

$37.780

-0.189 (-0.50%)At close

Loading chart…
High
37.835
Open
37.835
VWAP
37.76
Vol
1.73K
Mkt Cap
122.74M
Low
37.670
Amount
65.40K
EV/EBITDA, TTM
0.00

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.

kewaunee.com

AI analysis of Kewaunee Scientific Corp (KEQU)

hold

Kewaunee Scientific Corp is currently a hold. The stock's price is at $37.78, with a forward P/E ratio of 7.716, indicating it may be undervalued compared to its earnings potential. However, the company reported a significant decline in Q4 profit to $3.39 million from $4.85 million last year, which raises concerns about its profitability. Additionally, the RSI is at 68.842, suggesting the stock is nearing overbought territory, which may limit short-term upside. Investors should monitor the upcoming earnings report on September 9, 2026, for further insights into the company's performance.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 37.78
Low
Average
High

Valuation Metrics

The current forward P/E ratio for Kewaunee Scientific Corp (KEQU) is 7.72, compared to its 5-year average forward P/E of 12.73.

Forward P/E

Fair
5Y Average P/E
12.73
Current P/E
7.72
Overvalued
19.64
Undervalued
5.81

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
9.26
Current EV/EBITDA
0.00
Overvalued
13.57
Undervalued
4.95

Forward P/S

Undervalued
5Y Average P/S
0.53
Current P/S
0.00
Overvalued
0.81
Undervalued
0.25

Alphio AI Price Scenarios for KEQU

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%KEQU

$74.07

Scenario price

B

Base

Base · 50%KEQU

$63.47

Scenario price

B

Bear

Bear · 25%KEQU

$57.33

Scenario price

Events Timeline

2026-06-23 (ET)

17:30:00

Kewaunee Reports Q4 Revenue of $71.4M

2026-03-11 (ET)

16:10:00

Kewaunee Reports Q3 Revenue of $69.4M, Successfully Acquires Nu Aire

2025-09-10 (ET)

16:11:48

Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year

16:11:16

Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year

2025-03-12 (ET)

17:11:13

Kewaunee Scientific announces amendment to share repurchase program

News

KEQU FAQ — answered by Alphio AI

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. It operates in the Industrials sector (LABORATORY APPARATUS & FURNITURE industry).

Kewaunee Scientific Corp is currently a hold. The stock's price is at $37.78, with a forward P/E ratio of 7.716, indicating it may be undervalued compared to its earnings potential. However, the company reported a significant decline in Q4 profit to $3.39 million from $4.85 million last year, which raises concerns about its profitability. Additionally, the RSI is at 68.842, suggesting the stock is nearing overbought territory, which may limit short-term upside. Investors should monitor the upcoming earnings report on September 9, 2026, for further insights into the company's performance.

1 analysts cover KEQU: 1 rate it Buy, 0 Hold and 0 Sell.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started